Latest stories on SPRB
Spruce Biosciences to Participate in the H.C. Wainwright 28th Annual Global Investment Conference
StockTitan56 · neutralproduct/pr
Spruce Biosciences stock gains after analyst backs regulatory progress
InvestorsHub61 · neutralanalyst
Why is Spruce Biosciences stock gaining 4% today?
Investing.com Markets57 · neutralgeneral
Spruce Biosciences Announces Launch of MPS3BStudy.com
StockTitan56 · neutralproduct/pr
H.C. Wainwright reiterates Spruce Biosciences stock rating on BLA progress
Investing.com Analyst Ratings56 · neutralanalyst
FDA Alignment Puts Spruce Biosciences on Track for TA-ERT BLA Submission in Q4 2026
August 24, 2026
MarketChameleon73 · bullishproduct/pr
Spruce Biosciences Announces Positive Pre-BLA Meetings with FDA and Confirms BLA Submission for TA-ERT on Track for Q4 2026
StockTitan73 · bullishproduct/pr
Guggenheim lowers Spruce Biosciences stock price target to $104
Investing.com Analyst Ratings34 · bearishanalyst
Spruce Biosciences price target lowered to $104 from $123 at Guggenheim
The Fly42 · neutralanalyst
Cure Sanfilippo, National MPS agree to make $5.5M investment in Spruce
The Fly67 · bullishm&a
Spruce Biosciences sees cash runway into 2H27
The Fly56 · neutralgeneral
Spruce Biosciences reports Q2 EPS ($6.68), consensus ($5.93)
The Fly28 · bearishearnings
Silver Spruce to Settle Outstanding Indebtedness
StockTitan34 · bearishgeneral
Citizens cuts Spruce Biosciences stock price target on share dilution
Investing.com Analyst Ratings34 · bearishanalyst
Spruce Biosciences GAAP EPS of -$6.68
Seeking Alpha28 · bearishearnings
SPRUCE BIOSCIENCES, INC. (SPRB) files 8-K
SEC 8-K50 · neutralgeneral
Spruce Biosciences Reports Second Quarter 2026 Financial Results and Provides Corporate Updates
StockTitan53 · neutralearnings
Cure Sanfilippo Foundation and National MPS Society Make $5.5 Million Strategic Investment in Spruce Biosciences
StockTitan67 · bullishproduct/pr
Spruce Biosciences Appoints Jessica Cohen Pfeffer, M.D., as Vice President, Clinical Development
StockTitan63 · neutralgeneral
Spruce Biosciences Names Adrian Quartel Chief Medical Officer
TipRanks56 · neutralgeneral
SPRUCE BIOSCIENCES, INC. (SPRB) files 8-K
SEC 8-K50 · neutralgeneral
Spruce Biosciences Appoints Adrian Quartel, M.D., FFPM, as Chief Medical Officer
StockTitan56 · neutralgeneral
Spruce Biosciences Possibly First In-MPS IIIB Class Enzyme Replacement Therapy
Seeking Alpha67 · bullishproduct/pr
Spruce Biosciences Joins the Russell 3000® Index | SPRB Stock News
StockTitan63 · neutralgeneral